✓Tender information last checkedLast checked 8 Oct 2026, 18:13.
Opportunity overview
Provides the pharmacy element of the CMDU pathway, offering clinical review, interaction and renal dosing checks, patient counselling and the safe and urgent supply of oral COVID 19 treatments for eligible high risk patients.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.
Scope, procedure and submissions
Id
ocds-h6vhtk-06fb32
Main Procurement Category
services
Legal basis
Id
32014L0024
Scheme
CELEX
Classification
Scheme
CPV
Id
85100000
Description
Health services
Amendments
Entry 1
Id
1
Description
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using direct award process C.
The contract is paid on activity
The dates between which the services are intended to be provided are 1 April 2026 to 30 September 2027
Buyer, suppliers and contacts
Organisation 1
Name
NHS NOTTINGHAM AND NOTTINGHAMSHIRE INTEGRATED CARE BOARD
Id
GB-FTS-139719
Identifier
Legal Name
NHS NOTTINGHAM AND NOTTINGHAMSHIRE INTEGRATED CARE BOARD
No Identifier Rationale
notOnAnyRegister
Address
Street Address
Sir John Robinson House Sir John Robinson Way Arnold Nottingham
2 published notice versions reviewed by ProcuraAxis.
2 VERSIONS
1
087787-2026award, contract ·
2
095405-2026tenderUpdate ·
PROCURAAXIS ANALYSIS
ProcuraAxis Analysis
Our approved analysis of the opportunity appears below the official tender information.
ANALYSIS PREVIEW
Opportunity intelligence at a glance
NHS Nottingham and Nottinghamshire Integrated Care Board is seeking Hospital Pharmacy Services to support the CMDU pathway. The stated service includes clinical review, interaction and renal dosing checks, patient counselling, and safe urgent supply of oral COVID-19 treatments for eligible high-risk patients.
Who this may suit
Relevant to providers of hospital or clinical pharmacy services with capability to undertake medicines review, dosing and interaction checks, patient counselling, and urgent dispensing or supply. The notice metadata describes a limited award procedure without prior competition, so supplier participation arrangements are not stated.
Key points identified
Clinical pharmacy review capabilityProvide clinical review as part of the CMDU pharmacy pathway.Evidence: Description: "offering clinical review".
Medicines safety checksUndertake interaction and renal dosing checks.Evidence: Description: "interaction and renal dosing checks".
ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.
NHS Nottingham and Nottinghamshire Integrated Care Board is seeking Hospital Pharmacy Services to support the CMDU pathway. The stated service includes clinical review, interaction and renal dosing checks, patient counselling, and safe urgent supply of oral COVID-19 treatments for eligible high-risk patients.
Who this may suit
Relevant to providers of hospital or clinical pharmacy services with capability to undertake medicines review, dosing and interaction checks, patient counselling, and urgent dispensing or supply. The notice metadata describes a limited award procedure without prior competition, so supplier participation arrangements are not stated.
Key deliverables
Clinical review
Drug interaction checks
Renal dosing checks
Patient counselling
Safe and urgent supply of oral COVID-19 treatments for eligible high-risk patients
SUPPLIER REQUIREMENTS
6 criteria identified
Clinical pharmacy review capability
98% confidence
Provide clinical review as part of the CMDU pharmacy pathway.
View supporting evidence
Description: "offering clinical review".
Medicines safety checks
99% confidence
Undertake interaction and renal dosing checks.
View supporting evidence
Description: "interaction and renal dosing checks".
Patient counselling
99% confidence
Provide patient counselling.
View supporting evidence
Description: "patient counselling".
Urgent oral COVID-19 treatment supply
99% confidence
Provide safe and urgent supply of oral COVID-19 treatments for eligible high-risk patients.
View supporting evidence
Description: "the safe and urgent supply of oral COVID 19 treatments for eligible high risk patients".
Patient eligibility
98% confidence
Oral COVID-19 treatments are for eligible high-risk patients.
View supporting evidence
Description: "oral COVID 19 treatments for eligible high risk patients".
Supplier eligibility requirements
99% confidence
Unknown.
View supporting evidence
No supplier eligibility criteria are provided in the supplied notice data.
COMMERCIAL AND DELIVERY
Contract intelligence
Commercial
Contract value
99% confidence
Unknown.
View supporting evidence
Value minimum, value maximum and currency are null.
Commercial terms
99% confidence
Unknown.
View supporting evidence
No commercial terms are provided in the supplied notice data.
Delivery
Service scope
98% confidence
Pharmacy services supporting the CMDU pathway, including clinical checks, counselling and urgent treatment supply.
View supporting evidence
Opportunity description.
Delivery location
93% confidence
Unknown; buyer location is Nottingham (NG5 6DA).
View supporting evidence
Location is labelled "Buyer location" and gives Nottingham, NG56DA; no service delivery location is stated.
Contract dates
99% confidence
Unknown.
View supporting evidence
Contract start and end dates are null.
PROCEDURE
How to respond
Notice status
90% confidence
Open tender update.
View supporting evidence
display_status is "open"; notice_type is "tenderUpdate".
Procurement method
99% confidence
Limited.
View supporting evidence
procurement_method is "limited".
Procedure detail
99% confidence
Award procedure without prior publication of a call for competition.
View supporting evidence
procurement_method_details: "Award procedure without prior publication of a call for competition".
Submission deadline
99% confidence
Unknown.
View supporting evidence
submission_deadline is null.
RISKS AND UNKNOWNS
Points requiring attention
Procedure and status interpretation
98% confidence
The source labels the opportunity as open while also describing an award procedure without prior publication of a call for competition. Supplier participation or competition arrangements cannot be determined from the supplied data.
View supporting evidence
display_status: "open"; procurement_method_details: "Award procedure without prior publication of a call for competition".
No submission information
99% confidence
No submission deadline or submission requirements are provided.
View supporting evidence
submission_deadline is null; no documents are supplied.
Incomplete commercial and contractual information
99% confidence
Contract value, currency, start date, end date and commercial terms are not stated.
View supporting evidence
Value and contract-date fields are null; no commercial terms are supplied.
No lot information
99% confidence
No lots are supplied, so any lot-specific scope or requirements are unknown.
View supporting evidence
lots is an empty array.
ProcuraAxis analysis supplements, but does not replace, the original notice and tender documents. Always verify eligibility, deadlines and commercial terms with the issuing authority.
Continue in your ProcuraAxis workspaceFree account · Full approved analysis